Carfilzomib in combination with R-CHOP for initial treatment of patients with non-germinal center diffuse large B-cell lymphoma: a multicenter, single arm, phase 1/2 study.
Saved in:
| Title: | Carfilzomib in combination with R-CHOP for initial treatment of patients with non-germinal center diffuse large B-cell lymphoma: a multicenter, single arm, phase 1/2 study. |
|---|---|
| Authors: | Hill BT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Torka P; Roswell Park Comprehensive Cancer Centre, Buffalo, NY, USA., Hernandez-Ilizaliturri F; Roswell Park Comprehensive Cancer Centre, Buffalo, NY, USA., Dean R; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Jagadeesh D; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Karamlou K; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Fu CL; Cleveland Clinic Florida, Weston, FL, USA., Winter AM; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Ahmed W; Cleveland Clinic Florida, Weston, FL, USA., Smith M; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Mejia Garcia A; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Cooper B; University Hospitals, Cleveland Medical Center, Cleveland, OH, USA., Krauspe E; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Zhou J; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Brooks T; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Kacar M; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Thomas J; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Li H; Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA., Jia XS; Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA., Chen Y; Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA., Caimi P; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2025 Sep; Vol. 66 (9), pp. 1700-1709. Date of Electronic Publication: 2025 May 21. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study; Clinical Trial, Phase I |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40397818 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Carfilzomib in combination with R-CHOP for initial treatment of patients with non-germinal center diffuse large B-cell lymphoma: a multicenter, single arm, phase 1/2 study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hill+BT%22">Hill BT</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Torka+P%22">Torka P</searchLink>; Roswell Park Comprehensive Cancer Centre, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hernandez-Ilizaliturri+F%22">Hernandez-Ilizaliturri F</searchLink>; Roswell Park Comprehensive Cancer Centre, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Dean+R%22">Dean R</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Jagadeesh+D%22">Jagadeesh D</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Karamlou+K%22">Karamlou K</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Fu+CL%22">Fu CL</searchLink>; Cleveland Clinic Florida, Weston, FL, USA.<br /><searchLink fieldCode="AU" term="%22Winter+AM%22">Winter AM</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Ahmed+W%22">Ahmed W</searchLink>; Cleveland Clinic Florida, Weston, FL, USA.<br /><searchLink fieldCode="AU" term="%22Smith+M%22">Smith M</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Mejia+Garcia+A%22">Mejia Garcia A</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Cooper+B%22">Cooper B</searchLink>; University Hospitals, Cleveland Medical Center, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Krauspe+E%22">Krauspe E</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+J%22">Zhou J</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Brooks+T%22">Brooks T</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Kacar+M%22">Kacar M</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+J%22">Thomas J</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Jia+XS%22">Jia XS</searchLink>; Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Caimi+P%22">Caimi P</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2025 Sep; Vol. 66 (9), pp. 1700-1709. <i>Date of Electronic Publication: </i>2025 May 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Multicenter Study; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40397818 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2025.2504156 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1700 Titles: – TitleFull: Carfilzomib in combination with R-CHOP for initial treatment of patients with non-germinal center diffuse large B-cell lymphoma: a multicenter, single arm, phase 1/2 study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hill BT – PersonEntity: Name: NameFull: Torka P – PersonEntity: Name: NameFull: Hernandez-Ilizaliturri F – PersonEntity: Name: NameFull: Dean R – PersonEntity: Name: NameFull: Jagadeesh D – PersonEntity: Name: NameFull: Karamlou K – PersonEntity: Name: NameFull: Fu CL – PersonEntity: Name: NameFull: Winter AM – PersonEntity: Name: NameFull: Ahmed W – PersonEntity: Name: NameFull: Smith M – PersonEntity: Name: NameFull: Mejia Garcia A – PersonEntity: Name: NameFull: Cooper B – PersonEntity: Name: NameFull: Krauspe E – PersonEntity: Name: NameFull: Zhou J – PersonEntity: Name: NameFull: Brooks T – PersonEntity: Name: NameFull: Kacar M – PersonEntity: Name: NameFull: Thomas J – PersonEntity: Name: NameFull: Li H – PersonEntity: Name: NameFull: Jia XS – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Caimi P IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2025 Sep Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1029-2403 Numbering: – Type: volume Value: 66 – Type: issue Value: 9 Titles: – TitleFull: Leukemia & lymphoma Type: main |
| ResultId | 1 |